Dr George Frodsham
Founder & CEO at Medisieve
Speaker

Profile

Medisieve is developing and commercialising “magnetic blood filtration”, a new therapeutic platform to revolutionise the treatment of blood-borne diseases. It has raised £2.1M in equity funding and has won grants worth over £2M from the Wellcome Trust, Innovate UK, NIHR i4i and the EU Horizon 2020.

Agenda Sessions

Latest developments in solving the problem of AAV neutralising antibodies through physical depletion using magnetic haemofiltration
Dec 04, 09:30
View Session